Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-30

Clinical Trial Update: Insulin and the Polycystic Ovary Syndrome--Weight Reduction Study [NA]

View source ↗

Summary

This trial update notes the completion of a study evaluating insulin for weight reduction in Polycystic Ovary Syndrome, with obesity as a co-occurring condition…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Polycystic Ovary Syndrome, Obesity | NA | Status: COMPLETED